These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 24670360

  • 1. Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations.
    Cavalier E, Delanaye P, Lukas P, Carlisi A, Gadisseur R, Souberbielle JC.
    Clin Chem Lab Med; 2014 Aug; 52(8):1137-41. PubMed ID: 24670360
    [Abstract] [Full Text] [Related]

  • 2. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
    Cavalier E, Salsé M, Dupuy AM, Bargnoux AS, Watar F, Souberbielle JC, Delanaye P, Cristol JP.
    Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
    [Abstract] [Full Text] [Related]

  • 3. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M, Jean G, Bacri JL, Lemaitre V, Masy E, Joly D, Souberbielle JC.
    Clin Chem Lab Med; 2009 Apr; 47(3):362-6. PubMed ID: 19199835
    [Abstract] [Full Text] [Related]

  • 4. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P.
    Clin Lab; 2002 Apr; 48(3-4):131-41. PubMed ID: 11934215
    [Abstract] [Full Text] [Related]

  • 5. Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays.
    Schleck ML, Souberbielle JC, Delanaye P, Plebani M, Cavalier E.
    Clin Chem Lab Med; 2017 Jul 26; 55(8):1152-1159. PubMed ID: 28099122
    [Abstract] [Full Text] [Related]

  • 6. Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays.
    Valcour A, Zierold C, Blocki FA, Hawkins DM, Martin KJ, Rao SD, Bonelli F.
    Clin Chem Lab Med; 2018 Aug 28; 56(9):1476-1482. PubMed ID: 29750642
    [Abstract] [Full Text] [Related]

  • 7. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M, Migliardi M, Dutto F, Mengozzi G, Marranca D, Bagnis C, Berutti S, Gallone G, Aimo G, Ramello A, Fonzo D.
    G Ital Nefrol; 2002 Aug 28; 19(4):467-75. PubMed ID: 12369051
    [Abstract] [Full Text] [Related]

  • 8. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
    Caron P, Maiza JC, Renaud C, Cormier C, Barres BH, Souberbielle JC.
    Clin Endocrinol (Oxf); 2009 Apr 28; 70(4):533-8. PubMed ID: 18782355
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients.
    Donati G, Cianciolo G, Capelli I, Baraldi O, Gambaretto C, Demelas V, Marchetti A, La Manna G.
    Artif Organs; 2016 Oct 28; 40(10):1013-1016. PubMed ID: 26670936
    [Abstract] [Full Text] [Related]

  • 10. Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice?
    Dupuy AM, Bargnoux AS, Morena M, Lauret E, Souberbielle JC, Cavalier E, Cristol JP.
    Clin Chem Lab Med; 2018 Dec 19; 57(2):244-249. PubMed ID: 30183664
    [Abstract] [Full Text] [Related]

  • 11. Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism.
    Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC.
    J Clin Endocrinol Metab; 2005 Dec 19; 90(12):6370-2. PubMed ID: 16189258
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K, Ong L, Sethi SK, Saw S.
    Clin Biochem; 2013 Jun 19; 46(9):781-6. PubMed ID: 23384535
    [Abstract] [Full Text] [Related]

  • 13. Experience with a third-generation parathyroid hormone assay (BIO-PTH) in the diagnosis of primary hyperparathyroidism in a Brazilian population.
    Bonanséa TC, Ohe MN, Brandão C, Ferrer CF, Santos LM, Lazaretti-Castro M, Vieira JG.
    Arch Endocrinol Metab; 2016 Oct 19; 60(5):420-425. PubMed ID: 27812604
    [Abstract] [Full Text] [Related]

  • 14. The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma.
    Cavalier E, Daly AF, Betea D, Pruteanu-Apetrii PN, Delanaye P, Stubbs P, Bradwell AR, Chapelle JP, Beckers A.
    J Clin Endocrinol Metab; 2010 Aug 19; 95(8):3745-9. PubMed ID: 20519352
    [Abstract] [Full Text] [Related]

  • 15. A lower proportion of circulating active parathyroid hormone in peritoneal dialysis does not allow the pth inter-method adjustment proposed for haemodialysis.
    González-Casaus ML, González-Parra E, Sánchez-González C, Albalate M, de la Piedra-Gordo C, Fernández E, Torregrosa V, Rodríguez M, Lorenzo V.
    Nefrologia; 2014 May 21; 34(3):330-40. PubMed ID: 24798561
    [Abstract] [Full Text] [Related]

  • 16. Analytical validation of the new version of the Liaison N-Tact PTH assay.
    Cavalier E, Delanaye P, Carlisi A, Krzesinski JM, Chapelle JP.
    Clin Chem Lab Med; 2007 May 21; 45(1):105-7. PubMed ID: 17243925
    [Abstract] [Full Text] [Related]

  • 17. The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform.
    Cavalier E, Betea D, Schleck ML, Gadisseur R, Vroonen L, Delanaye P, Daly AF, Beckers A.
    J Clin Endocrinol Metab; 2014 Mar 21; 99(3):E453-7. PubMed ID: 24423313
    [Abstract] [Full Text] [Related]

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 21; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients.
    Hecking M, Kainz A, Bielesz B, Plischke M, Beilhack G, Hörl WH, Sunder-Plassmann G, Bieglmayer C.
    Clin Biochem; 2012 Dec 21; 45(18):1645-51. PubMed ID: 23217247
    [Abstract] [Full Text] [Related]

  • 20. [PTH measurement: where do we stand?].
    Marangella M.
    G Ital Nefrol; 2009 Dec 21; 26(5):600-7. PubMed ID: 19802805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.